Diagnostyka S.A. (WSE:DIA)
Poland · Delayed Price · Currency is PLN 162.60
-2.40 (-1.45%)
Last updated: Sep 24, 2026, 4:49 PM CET
Diagnostyka Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
| 2,585 | 2,410 | 1,950 | 1,588 | |
Revenue Growth | 19.18% | 23.60% | 22.81% | - |
Cost of Revenue | 552.2 | 505.03 | 420 | 401.71 |
Gross Profit | 2,032 | 1,905 | 1,530 | 1,186 |
Selling, General & Admin | 1,379 | 1,275 | 1,014 | 773.99 |
Other Operating Expenses | 45.11 | 45.09 | 17.59 | 35.06 |
Operating Expenses | 1,647 | 1,523 | 1,192 | 959.44 |
Operating Income | 385.82 | 382.7 | 338.01 | 226.83 |
Interest Expense | -69.2 | -68.86 | -57.37 | -54.2 |
Interest & Investment Income | 1.03 | - | - | 2.01 |
Earnings From Equity Investments | -0.27 | -0.19 | 1.61 | 0.06 |
Other Non Operating Income (Expenses) | 3.47 | 3.23 | 8.94 | -1.55 |
EBT Excluding Unusual Items | 320.49 | 316.88 | 291.19 | 173.16 |
Gain (Loss) on Sale of Investments | - | - | - | -4.98 |
Gain (Loss) on Sale of Assets | - | - | - | 3.53 |
Legal Settlements | - | - | - | -0.15 |
Other Unusual Items | - | - | - | 2.07 |
Pretax Income | 320.49 | 316.88 | 291.19 | 173.62 |
Income Tax Expense | 54.1 | 55.01 | 59.24 | 43.63 |
Earnings From Continuing Operations | 266.39 | 261.87 | 231.96 | 129.99 |
Minority Interest in Earnings | -11.5 | -10.27 | -8.63 | -6.56 |
Net Income | 254.88 | 251.6 | 223.33 | 123.43 |
Net Income to Common | 254.88 | 251.6 | 223.33 | 123.43 |
Net Income Growth | 6.18% | 12.66% | 80.93% | - |
Shares Outstanding (Basic) | 34 | 34 | 34 | 34 |
Shares Outstanding (Diluted) | 34 | 34 | 34 | 34 |
Shares Change | - | - | - | - |
EPS (Basic) | 7.55 | 7.45 | 6.62 | 3.66 |
EPS (Diluted) | 7.55 | 7.45 | 6.62 | 3.66 |
EPS Growth | 6.17% | 12.61% | 80.93% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Free Cash Flow | 317.84 | 346.99 | 282.72 | 254.66 |
Free Cash Flow Per Share | 9.42 | 10.28 | 8.38 | 7.54 |
Dividend Per Share | 4.400 | 4.400 | 3.310 | - |
Dividend Growth | 32.93% | 32.93% | - | - |
Gross Margin | 78.63% | 79.05% | 78.46% | 74.70% |
Operating Margin | 14.93% | 15.88% | 17.33% | 14.28% |
Profit Margin | 9.86% | 10.44% | 11.45% | 7.77% |
Free Cash Flow Margin | 12.30% | 14.39% | 14.50% | 16.04% |
EBITDA | 606.27 | 584.5 | 499.54 | 275.58 |
EBITDA Margin | 23.46% | 24.25% | 25.61% | 17.35% |
D&A For EBITDA | 220.45 | 201.79 | 161.53 | 48.75 |
EBIT | 385.82 | 382.7 | 338.01 | 226.83 |
EBIT Margin | 14.93% | 15.88% | 17.33% | 14.28% |
Effective Tax Rate | 16.88% | 17.36% | 20.34% | 25.13% |
Revenue as Reported | 2,604 | 2,424 | 1,975 | 1,597 |